CTX-M: changing the face of ESBLs in the UK

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1In Vitro and In Vivo Activities of Amikacin, Cefepime, Amikacin plus Cefepime, and Imipenem against an SHV-5 Extended-Spectrum β-Lactamase-Producing<i>Klebsiella pneumoniae</i>Strain2001 · 25 citations
2. 2Evolution of plasmid-coded resistance to broad-spectrum cephalosporins1985 · 420 citations
3. 3Early Dissemination of CTX-M-Derived Enzymes in South America2002 · 110 citations
4. 4Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat2001 · 2,639 citations
5. 5Outcome of Cephalosporin Treatment for Serious Infections Due to Apparently Susceptible Organisms Producing Extended-Spectrum β-Lactamases: Implications for the Clinical Microbiology Laboratory2001 · 547 citations